We are live on
!
Find out more
CA
Clearstead Advisors Portfolio holdings
AUM
$10.6B
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.42%
5 Year Est. Return
+80.33%
10 Year Est. Return
–
AUM
$7.93B
AUM Growth
+$314M
(+4.1%)
Cap. Flow
+$948M
Cap. Flow
% of AUM
11.95%
Top 10 Holdings %
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$727M |
| 2 |
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
|
+$32.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$19.7M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$14.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
|
+$29.8M |
| 2 |
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
|
+$10.7M |
| 3 |
Zoetis
ZTS
|
+$9.85M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$7.63M |
| 5 |
Norfolk Southern
NSC
|
+$4.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.05% |
| 2 | Financials | 6.74% |
| 3 | Industrials | 4.89% |
| 4 | Healthcare | 3.63% |
| 5 | Consumer Discretionary | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
iRadimed
IRMD
$1.15B
| $4.77K | ﹤0.01% |
49
| – | – |
|
2027
Itron
ITRI
$4.49B
| $4.74K | ﹤0.01% |
51
+19
| +59% | +$2.07K |
|
2028
nCino
NCNO
$2.08B
| $4.67K | ﹤0.01% |
+182
| New | +$4.62K |
|
2029
Gates Industrial Corporation Ltd.
GTES
$7.19B
| $4.66K | ﹤0.01% |
217
-1,023
| -83% | -$23.6K |
|
2030
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $4.63K | ﹤0.01% |
165
-88
| -35% | -$2.51K |
|
2031
Macerich
MAC
$6.9B
| $4.58K | ﹤0.01% |
248
| – | – |
|
|
GRAL
2032
GRAIL Inc
GRAL
$3.34B
| $4.54K | ﹤0.01% |
53
-248
| -82% | -$21.4K |
|
2033
Yum China
YUMC
$16.5B
| $4.54K | ﹤0.01% |
95
-2
| -2% | -$92 |
|
2034
Columbus McKinnon
CMCO
$557M
| $4.52K | ﹤0.01% |
262
-131
| -33% | -$2.1K |
|
|
VTYX
2035
DELISTED
Ventyx Biosciences
VTYX
| $4.51K | ﹤0.01% |
500
| – | – |
|
2036
NEOS S&P 500 High Income ETF
SPYI
$11.3B
| $4.47K | ﹤0.01% |
+85
| New | +$4.46K |
|
2037
Sun Communities
SUI
$14.4B
| $4.46K | ﹤0.01% |
36
| – | – |
|
2038
Ovid Therapeutics
OVID
$489M
| $4.46K | ﹤0.01% |
+2,734
| New | +$4.21K |
|
|
BCPC
2039
Balchem Corp
BCPC
$5.65B
| $4.45K | ﹤0.01% |
29
-17
| -37% | -$2.6K |
|
2040
Meritage Homes
MTH
$4.69B
| $4.34K | ﹤0.01% |
66
-242
| -79% | -$16.8K |
|
|
FTMU
2041
Franklin Municipal Income ETF
FTMU
$466M
| $4.29K | ﹤0.01% |
+549
| New | +$4.3K |
|
2042
Invesco China Technology ETF
CQQQ
$3.3B
| $4.26K | ﹤0.01% |
+82
| New | +$4.46K |
|
2043
Boot Barn
BOOT
$5.11B
| $4.24K | ﹤0.01% |
24
| – | – |
|
2044
SiteOne Landscape Supply
SITE
$4.34B
| $4.24K | ﹤0.01% |
34
+29
| +580% | +$3.67K |
|
2045
Asbury Automotive
ABG
$3.78B
| $4.19K | ﹤0.01% |
18
-17
| -49% | -$4.02K |
|
2046
Heron Therapeutics
HRTX
$63.4M
| $4.16K | ﹤0.01% |
3,200
-1,561
| -33% | -$1.93K |
|
2047
Moderna
MRNA
$23.9B
| $4.16K | ﹤0.01% |
141
+11
| +8% | +$299 |
|
2048
Greif
GEF
$4.97B
| $4.13K | ﹤0.01% |
61
+19
| +45% | +$1.19K |
|
2049
TriplePoint Venture Growth BDC
TPVG
$212M
| $4.12K | ﹤0.01% |
+630
| New | +$3.77K |
|
2050
TG Therapeutics
TGTX
$7.52B
| $4.08K | ﹤0.01% |
137
+1
| +0.7% | +$33 |
|
Similar funds
PF
BMSSC
HTC
VPIM
ACA
GI
RA
RI
Clearstead Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Clearstead Advisors deployed $948M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.
- Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
- Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
- Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
- Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
- Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
- Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
- Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.
Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.